SBIR/STTR Research Award
Handheld Two Photon Microscopy Imager
Award amount
$224,980Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PHYSICAL SCIENCES INC.
- Proposal award date
- 2017-09-18
- Contract end date
- 2018-08-31
- UEI
- RMG1AZ1ZH8Q7
- Solicitation number
- PA16-302
- Topic code
- 102
Research abstract
Project Summary Abstract
Physical Sciences Inc PSI proposes to develop a handheld two photon microscopy TPM probe that will
enable in vivo diagnosis and screening of various diseases including cancers This novel clinically usable
TPM instrument will provide three dimensional D sub micron resolution images of tissue pathology in
situ The images generated based on the two photon excitation signals of intrinsic bio molecules such as
the two photon excited fluorescence TPEF of endogenous fluorophores and the second harmonic
generation SHG of collagen will render important morphological and molecular information specific to
various pathologies
Noninvasive optical biopsy based on two photon microscopy is considered as the next generation
technology for disease diagnosis and has already been investigated in many pre clinical studies However
a suitable clinical TPM instrument has not yet been demonstrated which is largely due to the technical and
cost barriers in developing such a sought after system These include difficulty in transmitting high power
broadband femtosecond pulses from the bulky laser to a hand held probe through a flexible fiber cord
challenges in miniaturizing the imaging probe with no sacrifice of imaging performance and the high cost
of the ultrafast laser source needed for efficient excitation of the nonlinear optical processes Therefore
this Randamp D program directly addresses these barriers to widespread clinical use of TPM for noninvasive
pathology A laboratory prototype will be developed in the Phase I to demonstrate feasibility while further
optimization advanced engineering and clinical testing will be performed in Phase II Innovative
technologies including the development of a specialty fiber module for delivery of high power ultrashort
pulses and generation of a coherent supercontinuum SC based on the fiber delivered laser pulses as
well as novel technological approaches for building a compact light weight imaging probe are being
proposed This will be possible by leveraging the expertise of a multidisciplinary team of investigators from
PSI with a proven track record on developing the next generation clinical devices a leading research
group from University of Illinois at Urbana Champaign and experienced clinical researchers and
pathologists from Memorial Sloan Kettering Cancer Center
Project Narrative
The purpose of this proposed research is to develop a clinical two photon microscopy TPM imager The
proposed instrument will include a handheld imaging probe that will be demonstrated during the Phase I
program This instrument will enable crucial and extensive clinical investigations of the TPM based optical
biopsy method for noninvasive and real time diagnosis of human diseases such as skin melanoma and
oral cancer during the second phase of development Successful completion of the TPM imager
development and application will eventually lead to a new gold standard for biopsy and histopathological
analysis
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Bio-inspired Energy Dissipating Structures for Enhanced Airdrop Capabilities
- Off-axis Laser Event Recorder (OALER)
- Scalable, Controllable Inductive Arrays for Weld Heating
- TFLN Interconnect for Gigabit-rate Environment Ruggedization (TIGER)
- Modular Bypass Valve for Solid Fuel Ramjets
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MiREA, a mHealth intervention to Reduce Health Disparities by Improving Equitable Access to Mandated College Students with Problematic Alcohol and Marijuana Use
- Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
- Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
- Allogeneic cell and gene therapy for neuroendocrine tumors
- Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer